Senior FP&A Analyst

The Senior FP&A Analyst will play a critical role in supporting corporate and program level planning, budgeting, and forecasting. This individual will partner closely with R&D, Program Management, Clinical, Tech Ops, and G&A teams to deliver high‑quality financial insights, support decision‑making, and ensure disciplined financial management in a dynamic, science‑driven environment.

This role is ideal for someone who thrives in high‑growth biotech, can balance strategic thinking with hands‑on execution, and is excited to build scalable FP&A processes.

• Lead the annual operating plan, long‑range planning (LRP), and quarterly forecasting cycles across all functions
• Build driver‑based financial models to support forecasting accuracy and scenario analysis
• Support implementation and optimization of ERP and planning tools to build scalable FP&A reporting infrastructure, including dashboards, forecast templates, and process improvements
• Prepare monthly and quarterly financial reporting packages for leadership, highlighting key variances, trends, and actionable insights
• Partner with Program Management and functional leads to manage cross‑functional program budgets and timelines
• Support accruals related to external CRO/CMO partners, milestone‑based spend, and clinical site activity
• Partner with Accounting on monthly close, accruals, cost center reporting, and flux analysis
• Support headcount planning, hiring forecasts, and workforce modeling in partnership with HR and hiring managers
• Assist with vendor contract reviews for financial accuracy and budget alignment

• Bachelor’s degree in Finance, Accounting, Economics, or related field.
• 3–5+ years of progressive FP&A or Finance experience, ideally within biotech or pharma
• Experience supporting R&D, clinical development, or other multi‑program environments
• Experience with biotech planning cycles (e.g., program budgeting, CRO/CMO forecasting) preferred
• Familiarity with ERP systems, planning tools, and business intelligence platforms (e.g., Net Suite, Adaptive Insights a plus)
• Demonstrated ability to partner cross‑functionally and communicate complex concepts clearly
• Ability to manage competing priorities and operate in a fast‑paced, high‑growth environment
• Highly analytical with strong attention to detail
• Proactive problem solver who anticipates needs
• Strong interpersonal skills and business judgment
• Collaborative team player

• Opportunity to join a mission‑driven team where you'll contribute to impactful work, take on varied responsibilities, and grow quickly in a dynamic environment
• Competitive compensation, including base salary, performance bonus, and equity
• 100% employer‑paid benefits package
• Flexible PTO; also, two, one‑week company‑wide shutdowns each year
• A commitment to your professional development, with access to resources, mentorship, and growth opportunities

• Crescent Biopharma’s vision is to build a world‑leading oncology company bringing the next wave of therapies for cancer patients. The company’s clinical‑stage pipeline includes its lead program, a PD‑1 x VEGF bispecific antibody, as well as novel antibody‑drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors.
  
  For more information, visit  and follow the Company on Linked In and X.

$105,000 - $125,000 a year

The final salary offered will depend on several factors, which may include, but is not limited to relevant years of experience, educational background, and geography. Subject to the terms of their respective plans, employees and/or eligible dependents are eligible to participate in the following company‑sponsored employee benefit programs: medical, dental, vision, life insurance, short‑ and long‑term disability. Subject to the terms of their respective plans, employees are eligible to participate in the company’s savings plan (401(k)).

This position is eligible to participate in the company’s long‑term incentive program. Subject to the terms of their…